A Study to Assess the Safety of Hep C Vaccine Candidates in HIV Seropositive Individuals

NCT02568332 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Oxford

Collaborators